Literature DB >> 10631859

The pathologic spectrum of gastrointestinal and hepatic histoplasmosis.

L W Lamps1, C P Molina, A B West, R C Haggitt, M A Scott.   

Abstract

We characterized the pathologic spectrum of lesions in gastrointestinal and hepatic histoplasmosis by studying cases of disseminated disease in immunocompromised and immunocompetent patients from endemic and nonendemic areas. We evaluated 56 specimens from 52 patients with H&E and silver stains. Of these patients, 43% presented with gastrointestinal rather than pulmonary symptoms. Thirty-one percent had gastrointestinal lesions, 10% had liver lesions, and 43% had both. Gross gastrointestinal features included ulcers (49% of patients), nodules (21%), hemorrhage (13%), obstructive masses (6%) and normal mucosa (23%). Microscopic gastrointestinal findings included diffuse lymphohistiocytic infiltration (83%), ulceration (45%), lymphohistiocytic nodules (25%), or minimal inflammatory reaction (15%) but only rare well-formed granulomas (8.5%). The most common hepatic finding was portal lymphohistiocytic inflammation; discrete hepatic granulomas were seen in less than 20% of involved livers. The pathologist must be aware of the broad range of gastrointestinal and hepatic lesions produced by histoplasmosis and, in particular, that well-formed granulomas are rare. Given the appropriate clinical context, histoplasmosis should be considered in both immunocompetent and immunocompromised patients, regardless of pulmonary symptoms, in nonendemic as well as endemic areas.

Entities:  

Mesh:

Year:  2000        PMID: 10631859     DOI: 10.1309/X0Y2-P3GY-TWE8-DM02

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  29 in total

1.  [Pulmonary nodules in a patient with high temperature. Acute pulmonary histoplasmosis].

Authors:  F Kiessling; T Junghanss; K Tintelnot; H-P Schlemmer
Journal:  Radiologe       Date:  2003-10       Impact factor: 0.635

2.  Disseminated histoplasmosis in an HIV-infected patient discovered by routine blood smear staining.

Authors:  R Matulionyte; J Garbino; I Uçkay; J F Lambert; B Hirschel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-05       Impact factor: 3.267

Review 3.  Histoplasmosis: a clinical and laboratory update.

Authors:  Carol A Kauffman
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

4.  Colonic histoplasmosis: a difficult diagnostic problem.

Authors:  Georgios Psarros; Carol A Kauffman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

5.  Disseminated histoplasmosis in a patient with aplastic anemia.

Authors:  Sanjeev Kumar Sharma; Sunil Gupta; Prashant Durgapal; Anjan Mukherjee; Tulika Seth; Pravas Mishra; Manoranjan Mahapatra; Immaculata Xess; Ruma Ray; Sanjay Sharma
Journal:  Indian J Hematol Blood Transfus       Date:  2012-10-09       Impact factor: 0.900

6.  Identification of Histoplasma capsulatum from culture extracts by real-time PCR.

Authors:  Jose Martagon-Villamil; Nabin Shrestha; Mary Sholtis; Carlos M Isada; Gerri S Hall; Terry Bryne; Barbara A Lodge; L Barth Reller; Gary W Procop
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

7.  Disseminated histoplasma and CMV infection presenting as subacute intestinal obstruction in an immunocompromised patient.

Authors:  Lokesh Shahani
Journal:  BMJ Case Rep       Date:  2012-05-08

Review 8.  Infectious diseases and the liver.

Authors:  Rohit Talwani; Bruce L Gilliam; Charles Howell
Journal:  Clin Liver Dis       Date:  2011-02       Impact factor: 6.126

Review 9.  Asymptomatic Histoplasma Pylephlebitis in an Orthotopic Liver Transplant Recipient: A Case Report and Literature Review.

Authors:  Pakpoom Phoompoung; Methee Chayakulkeeree; Popchai Ngamskulrungroj; Ananya Pongpaibul
Journal:  Mycopathologia       Date:  2018-05-22       Impact factor: 2.574

10.  Intestinal histoplasmosis in immunocompetent adults.

Authors:  Lin-Lin Zhu; Jin Wang; Zi-Jing Wang; Yi-Ping Wang; Jin-Lin Yang
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.